Hydrothermal architecture of Cu5V2O10 nanostructures as new electro-sensing catalysts for voltammetric quantification of mefenamic acid in pharmaceuticals and biological samples

Abstract

A novel nano-electrocatalyst based on Cu5V2O10 is successfully fabricated by one-pot hydrothermal treatment and used for the examination of mefenamic acid (MFA) in real samples, for the first time. Controlling the combined factors of complexing agent's (4, 4′-Diaminodiphenylmethane, DDM) molar ratio, hydrothermal temperature, and reaction time is responsible for providing the optimal structural and morphological changes of the crystals. The effect of operating conditions of Cu5V2O10 nanostructures is investigated using FT-IR, XRD, and EDX as structural and elemental analyses. Also, other properties such as particle size and morphological studies were accomplished by FE-SEM, and HR-TEM. The results reveal that the monoclinic phase of Cu5V2O10 with particle size of 34 nm is the outcome of hydrothermal treatment of 200 °C for 18 h, which DDM template with molar ratio of 2.0 M serves as phase stabilizing matrix. Herein, it is demonstrated the electrochemical biosensing characteristics of the nano-scale Cu5V2O10 modified carbon paste electrode (CV/CPE) by voltammetry techniques. The drug sensing capabilities of the boosted CV/CPE platform exhibit linear dynamic range of 0.01–470 μM, and low detection limit of 2.34 nM with excellent sensitivity and selectivity. The appropriate electrical conductivity and layered structure of the compound causes a valuable platform for minimally invasive assessment of MFA in biological and pharmaceutical media with recovery rate of 98.3%–110.0% and 93.6%–106.7%, respectively. As a result, the proposed nanostructures as great candidate offer excellent electrocatalytic activity in biomedicine applications.